Page 9 - Pharma

Supriya Lifescience IPO fully subscribed within few hours of opening

On Wednesday, the company raised Rs 315 crore from anchor investors

Medical device, pharmaceutical units in NCR allowed to use diesel gensets

Factories making pharmaceuticals, medical devices, life saving medical equipment can use diesel gensets to run their plants, said the Commission for Air Quality Management in NCR & Adjoining Areas.

Bill to enhance status of 6 institutes of pharma edu, research gets Parl OK

The National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021, passed by the Lok Sabha on December 6, was cleared in the Rajya Sabha on Thursday with a voice vote

Dr Reddy's launches drug in US to treat high blood pressure, heart failure

The tablet is the generic therapeutic equivalent of Diovan, approved by the US Food and Drug Administration

IT, pharma segments may not provide hedge if rupee weakens

There are concerns over margin and growth, which may weigh on sentiment

Alembic Pharma gets USFDA nod for formoterol fumarate inhalation solution

Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US Food & Drug Administration (USFDA) for its generic version of formoterol fumarate inhalation solution used for the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. The approval for the abbreviated new drug application (ANDA) for formoterol fumarate inhalation solution is for 20 mcg/2 ml per unit-dose vial. It is therapeutically equivalent to Mylan Specialty's 'Perforomist Inhalation Solution', 20 mcg/2 ml per unit-dose vial, Alembic Pharmaceuticals said in a regulatory filing. The formoterol fumarate inhalation solution indicated for long term, twice daily -- morning and evening -- administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, it added. "This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Pvt .

Zydus Cadila gets USFDA nod to market generic cancer drug in US

The drug will be manufactured at the group's injectables manufacturing facility

Our aim is to create ecosystem to make India lead in drug discovery: PM

India has a large pool of scientists and technologists with a potential to take the industry to greater heights, says PM Modi at Global Innovation Summit of the Pharmaceuticals sector

Piramal Enterprises board approves to demerge and list pharma business

The demerger will give potential investors the option of being associated with the business of their choice

MakeMyTrip sees 100% return to travel in pharma, realty, other corp sectors

Firm's recent market study says financial services, IT, consumer goods and auto are the laggards, may be the last ones to see a complete recovery in corporate travel

Charting growth: Acute therapy drugs make a comeback in July, shows data

But a fall in doctor visits hit acute therapy drugs. July saw a major turnaround

Biocon partners Adagio for licence to make Covid-19 antibody cocktail

Treatment claims to address the resistant Delta variant as well

Biocon Biologics gets licence from Adagio for antibody Covid treatment

Initial data indicate that ADG20 could provide both rapid and durable protection against Covid-19 for up to one year

Why switching over to laggards may prove rewarding in stock market

FMCG, Pharma and Energy are sectors that have delivered lower returns than benchmark indices in the past year

Hetero recalls a batch of its remdesivir brand Covifor after side effects

Some patients in Raigad district of Maharashtra developed side effects like fever and chills

Key Covid-19 bulk drugs see 180% price increase over four months

However, there is no shortage expected at the retail level anytime soon

Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step

Single dose of Pfizer vaccine cuts Covid-19 spread by half: Study

Protection against coronavirus seen from about 14 days after vaccination

25 new plants approved to enhance supply of Remdesivir: Mandaviya

The government was working hard to enhance the production of antiviral drug Remdesivir to 300,000 vials per day, the minister said

Cadila Healthcare's Hepatitis C drug gets approval for emergency use

Approval from the drug regulator follows late-stage study of the medicine